Kate Townsend Creasy

机构：Translational Therapeutics (United States), University of Pennsylvania · ORCID：0000-0003-1870-4586

发表论文 63 篇 · 总被引 924 次 · h-index 14

代表论文

• A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids (2024 · Hepatology Communications · 被引 42)
• Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types (2023 · Nature Communications · 被引 24)
• Aspirin is associated with a reduced incidence of liver disease in men (2023 · Hepatology Communications · 被引 14)
• The Lipidomic Profile Discriminates Between MASLD and MetALD (2025 · Alimentary Pharmacology & Therapeutics · 被引 13)
• Mimicking opioid analgesia in cortical pain circuits (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 13)
• mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b (2024 · Journal of Clinical Investigation · 被引 13)